AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

IL-17 signaling pathway in SPP1+ macrophages drives digestive tract cancer progression

Yihong Weia,1Ying Xub,1Yanqiong ZengcAmin ZhangaXiangling Xingd( )Wancheng Liua( )
Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China
Eye Hospital of Shandong First Medical University, Jinan, Shandong 250012, China
National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu 215123, China
Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China

1 These authors contributed equally to this work.

Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA)

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Article number: 101489

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Wei Y, Xu Y, Zeng Y, et al. IL-17 signaling pathway in SPP1+ macrophages drives digestive tract cancer progression. Genes & Diseases, 2025, 12(4): 101489. https://doi.org/10.1016/j.gendis.2024.101489

273

Views

1

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 25 February 2024
Published: 14 December 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).